Recent regulatory scrutiny in Germany has cast a spotlight on misoprostol (Angusta) and its role in labour induction, raising significant safety concerns. As this conversation unfolds across Europe, healthcare professionals are re-evaluating their induction protocols and looking to non-pharmacological methods like DILAPAN-S as a safer alternative.

Your Quarterly Update on Innovations in Women’s Health Welcome to the July 2025 edition of AGHeadlines , where we share the latest...

What activities counts towards your CPD hours? Find links to free learning resources and NMC approved courses in this article.

These 30-minute sessions are hosted by a DILAPAN-S specialist, offering an opportunity to obtain your DILAPAN-S certification.

Advice from experienced healthcare professionals on finding success with mechanical IOL methods

As clinicians, it is necessary to adapt our skills to deliver new techniques and enable advances in practice. Clinicians should be...

Pregnancy and childbirth are monumental experiences for families, and it is our duty to provide them with the best possible memories. The...

We all have experiences of those births that just seem to go seamlessly; experiences that make us remember, throughout the chaos that is...